Showing results (781-790 of 977) with videos related to

Sort By:
Pageof 98
Frontiers in Human Neuroscience|June 28, 2019
Disparities in Diffuse Cortical White Matter Integrity Between Socioeconomic GroupsDanielle Shaked, Daniel K Leibel, Leslie I Katzel, et al.
Cell Death Discovery|September 26, 2021
Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibitionDavid Junk, Sebastian Krämer, Johannes Broschewitz, et al.
International Journal of Cancer|July 8, 2010
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumorKatrin Singer, Michael Kastenberger, Eva Gottfried, et al.
Plos One|June 16, 2016
Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls)Helmuth Haslacher, Sonja Nistler, Delgerdalai Batmyagmar, et al.
Circulation|February 5, 2017
High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis)Stephen L Seliger, Susie N Hong, Robert H Christenson, et al.
Oncoimmunology|March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patientsLe Tong, Veronika Kremer, Shi Yong Neo, et al.
European Journal of Neurology|October 19, 2022
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up studySofia Doubrovinskaia, Christoph M Mooshage, Corinna Seliger, et al.
Journal of Cardiac Failure|January 30, 2008
Cystatin C concentration as a predictor of systolic and diastolic heart failureAndrew Moran, Ronit Katz, Nicolas L Smith, et al.
International Journal of Cancer|August 18, 2010
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2Kousaku Mimura, Takashi Ando, Isabel Poschke, et al.
Plos One|October 7, 2015
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer CellsRiki Okita, Diana Wolf, Koichiro Yasuda, et al.
Pageof 98